The Aperlena Verdict
Open raceNo supplier dominates: 263 different companies have won the last 742 comparable contracts from this buyer over 5 years. This is a genuinely open race.
- 0%
- Expected final price vs the published estimate
Based on 742 comparable awards by this buyer in this sector over 5 years. Every verdict is recorded before the outcome and graded against the award notice. How we score ourselves.
Summary
Machine-generated summaryThis tender concerns the purchase of Adalimumab 40 mg/0.8 ml, a solution for injection presented in 0.8 ml vials for subcutaneous administration. Adalimumab is a biologic medicine used to treat chronic inflammatory conditions, so the contract covers the supply of this medicinal product to a healthcare purchaser. The notice names the specific pharmaceutical presentation to be delivered, including the strength of 40 mg per 0.8 ml and the injectable solution format. Only one product type is identified in the description, indicating a single procurement scope focused on this medicine. Supply arrangements would support patient treatment with this biologic therapy under the resulting contract.
Official source
Source: BASE - Portal dos Contratos Públicos (IMPIC)
Always verify details on the official notice.
Last verified against BASE - Portal dos Contratos Públicos (IMPIC) 4 hours ago
More from this buyer
Full buyer profile396 open tenders right now
- Supply of compresses, PVC tubes, catheters, bundles, assorted wires and other medical devices for 2026 3 days left
- Healthcare services - Provision of healthcare and management of Model C Family Health Units (USF-C) in Catujal, municipality of Loures 4 days left
- Medical equipment - 12027626 - Posterolateral dorsal-lumbar spine osteosynthesis material 15 days left
Who usually wins this buyer's contracts in this sector
| Company | Wins | Total awarded | Last win |
|---|---|---|---|
| MEDARTHREX UNIPESSOAL, LDA | 21 | €47,590 | Sep 2026 |
| Smith & Nephew, Lda. | 19 | €155,813 | Sep 2026 |
| ACCORD HEALTHCARE UNIPESSOAL LDA | 18 | €207,131 | Aug 2026 |
| MYLAN, LDA | 17 | €313,495 | Sep 2026 |
| SANDOZ FARMACEUTICA, LDA | 16 | €357,937 | Aug 2026 |
Based on 742 awards with a linked company profile over the last 5 years.
What this buyer has paid before
Based on 748 comparable contracts this buyer awarded in this sector over the last 4 years.
- €2,602
- Lower quartile
- €9,380
- Median award
- €40,403
- Upper quartile
This tender is estimated 1034.4% above that median
Most recent awards
- 42051026 Aquisição de cavilha intramedular e outros dispositivos €1,356
- AQUISIÇÃO DE HEXAFLUORETO DE ENXOFRE 8 ¿G/ML PÓ DISP INJ SER IV - AQ 2024/960 €5,723
- Cateter Endovenoso Veia Periférica 22G €360
- Aquisição de VINORRELBINA 30 MG CÁPS €792
- AQUISIÇÃO DE PANITUMUMAB 20 MG/ML SOL INJ FR 20 ML IV - AQ 2023/491 €21,128
Award values as published by the official sources. Use them as a guide, not a rule: scope, lots and duration differ between contracts.
Similar tenders
1
day left
€134,750
est. value
Market context
- Avg. open tender · Medical equipment & pharmaceuticals
- €10,113,906
- Buyer track record on Aperlena
- 4,008 notices tracked · 955 awarded
- €62,656,713 in awarded contracts
Never miss a tender like this
10,471 new notices in Medical equipment & pharmaceuticals in Portugal in the last 7 days. Get an email when new ones appear. Free.
Set up my alert